DepoCyt for Active Lymphomatous or Leukemic Meningitis
Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the response rate of lymphomatous meningitis or
leukemic meningitis to DepoCyt. The safety of DepoCyt, the number of people who respond well
to the study drug, and the response of symptoms to the study drug will also be determined.